Health Discovery receives MICO Award from MDB Capital at Bright Lights Conference

Health Discovery Corporation (OTCBB: HDVY) announced today it received the prestigious MICO Award presented by MDB Capital Group, San Francisco, Calif., at its invitation-only Bright Lights Conference held May 11-12, 2010. Health Discovery Corporation was chosen from among 1,600 publicly traded, small cap companies.

“MDB Capital built PatentVest to help investors easily assign a tangible value to patents, and we've proven that market leading IP is predictive of superior business performance. Companies like Health Discovery Corporation typify the market leading IP presented at our Bright Lights Conference”

The MICO Award is Latin for "to shine." The award was presented to the Top 5 companies across all industries with the most potentially disruptive or market changing intellectual property. "Disruptive technologies" is a term used in business and technology to describe innovations that improve a product or service in ways that the market does not expect.

According to PatentVest, MDB Capital's proprietary intellectual property (IP) analytical tool, "Among public companies in the healthcare industry, our IP metrics found that Health Discovery Corporation is a leading innovator of game-changing IP," said Christopher Marlett, Co-Founder, Chairman & CEO, MDB Capital Group.

"Intellectual property is no longer an intangible asset class," said Marlett. "MDB Capital built PatentVest to help investors easily assign a tangible value to patents, and we've proven that market leading IP is predictive of superior business performance. Companies like Health Discovery Corporation typify the market leading IP presented at our Bright Lights Conference," said Marlett.

"Health Discovery Corporation ranks as a market leader in each of the quantitative metrics across the entire health care sector," said Marlett.

"We are honored to receive the MICO Award from MDB Capital and this independent validation of our market changing intellectual property," said Stephen D. Barnhill, Chairman and CEO, Health Discovery Corporation.

"The resources invested by MDB Capital in the creation of its rigorous PatentVest analytic tool and applied to our patent portfolio further confirms the value of Health Discovery Corporation's intellectual property portfolio," said Dr. Barnhill.

"Companies like Quest Diagnostics, Incorporated (NYSE: DGX) and Abbott Labs (NYSE: ABT) understand the value of Health Discovery Corporation's patent protected technology and have entered into significant development and commercialization contracts with us," said Dr. Barnhill. "Our patented technology also attracts world-class scientist-inventors like Isabelle Guyon, Ph.D. and Maher Albitar, M.D. to our company," said Dr. Barnhill.

"An unsung hero in all of this is our long-time intellectual property lawyer, Eleanor Musick, a partner at the law firm, Procopio, Cory, Hargreaves & Savitch LLP in San Diego, California," said Dr. Barnhill. "Eleanor's vast knowledge of patent law, her scientific expertise and strategic thinking and planning have been invaluable in creating the value in our intellectual property portfolio that was recognized publicly by MDB Capital Group selecting HDC for their prestigious MICO Award," he said.

"I am thrilled to see Health Discovery Corporation receive this honor in recognition of its vision for SVM technology and am happy to have had the opportunity to participate in designing and carrying out a strategy for patent protection of this versatile technology and the valuable discoveries it has produced," said patent lawyer Eleanor Musick.

"It has been a pleasure working with Health Discovery's impressive inventors and with Dr. Barnhill and his team over the past ten years," said Musick. "I look forward to working with Health Discovery as it continues its tradition of innovation and to securing additional intellectual property protections for Health Discovery's future inventions and discoveries," said Musick.

Source:

Health Discovery Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Google unveils PHIA: AI-powered insights from your wearable health data